FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2592012037> ?p ?o ?g. }

• W2592012037 endingPage "19" @default.
• W2592012037 startingPage "14" @default.
• W2592012037 abstract "Earlier, we verified that Melissa officinalis extract (MOE) elicits potent antiproliferative effects on different human cancer cells. To gain insights into the molecular mechanisms accounting for the cytotoxic effects of MOE, we assessed the expression patterns of several prominent molecules with therapeutic potential in cancer by Quantitative PCR (Q-PCR).A549, MCF-7 and PC3 cancer cells were grown in complete RPMI 1640 and seeded in 24 well micro plates. After incubation for 72h, 100μg/ml of MOE was added and the cells were further incubated for 72h. Afterwards, the cells were subjected to RNA extraction for the means of Q-PCR.Our results indicated that in PC3 cancer cells, MOE resulted in a significant downregulation of VEGF-A (0.0004 fold), Bcl-2 (0.001 fold), Her2 (0.02 fold), and hTERT (0.023 fold) compared to the untreated control. In addition, VEGF-A and hTERT mRNA were significantly downregulated in MCF-7 and A549 cancer cells, as well. Notably, high anti-angiogenic activity was closely associated with a high anti-telomerase activity of MOE in studying cancer cells. The decrease in VEGF-A expression was significantly superior than that of hTERT downregulation, as PC3 cancer cells with the highest hTERT down regulation (0.023) presented the highest anti VEGF activity (0.0004 fold), whereas MCF-7 cells with the lowest hTERT inhibition (0.213) showed the lowest VEGF inhibition(0.0435) among the three studied cancer cells. We noticed that the modulation of VEGF-A and hTERT gene expression can be considered as a common target, accounting for the therapeutic potential of MOE on human breast, lung and prostate cancer cells.Altogether, it is suggested that the potent antiproliferative activity of the hydroalcoholic extract of Melissa officinalis is somehow explainable by its high potency to inhibit expression of the prominent oncogenes Bcl2, Her2, VEGF-A and hTERT in prostate cancer. In tumors with functional p53, including MCF-7 and A549 cancer cells, the role of p53, Bcl2 and Her2 is less significant. It appears that MOE exerts its antiproliferative effects in these cancer cells partly via concurrent downregulation of VEGF-A and hTERT. Additional studies are needed to clarify the role of other active molecules in cancer cells harboring functional p53." @default.
• W2592012037 created "2017-03-16" @default.
• W2592012037 creator A5001534314 @default.
• W2592012037 creator A5017660016 @default.
• W2592012037 creator A5037974804 @default.
• W2592012037 creator A5050090015 @default.
• W2592012037 creator A5053329507 @default.
• W2592012037 creator A5057611294 @default.
• W2592012037 creator A5083824515 @default.
• W2592012037 date "2017-05-01" @default.
• W2592012037 modified "2023-10-01" @default.
• W2592012037 title "The herbal medicine Melissa officinalis extract effects on gene expression of p53, Bcl-2, Her2, VEGF-A and hTERT in human lung, breast and prostate cancer cell lines" @default.
• W2592012037 cites W1972739162 @default.
• W2592012037 cites W1984358846 @default.
• W2592012037 cites W1992487885 @default.
• W2592012037 cites W2007704906 @default.
• W2592012037 cites W2038441188 @default.
• W2592012037 cites W2045991390 @default.
• W2592012037 cites W2075897182 @default.
• W2592012037 cites W2078632611 @default.
• W2592012037 cites W2092595655 @default.
• W2592012037 cites W2112911107 @default.
• W2592012037 cites W2114348409 @default.
• W2592012037 cites W2139887884 @default.
• W2592012037 cites W2258967238 @default.
• W2592012037 cites W2291438132 @default.
• W2592012037 cites W2300904063 @default.
• W2592012037 cites W2343423203 @default.
• W2592012037 cites W2395289121 @default.
• W2592012037 cites W2405152921 @default.
• W2592012037 cites W2464356132 @default.
• W2592012037 cites W4255447175 @default.
• W2592012037 cites W632573003 @default.
• W2592012037 doi "https://doi.org/10.1016/j.gene.2017.02.034" @default.
• W2592012037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28259690" @default.
• W2592012037 hasPublicationYear "2017" @default.
• W2592012037 type Work @default.
• W2592012037 sameAs 2592012037 @default.
• W2592012037 citedByCount "22" @default.
• W2592012037 countsByYear W25920120372017 @default.
• W2592012037 countsByYear W25920120372018 @default.
• W2592012037 countsByYear W25920120372019 @default.
• W2592012037 countsByYear W25920120372020 @default.
• W2592012037 countsByYear W25920120372021 @default.
• W2592012037 countsByYear W25920120372022 @default.
• W2592012037 crossrefType "journal-article" @default.
• W2592012037 hasAuthorship W2592012037A5001534314 @default.
• W2592012037 hasAuthorship W2592012037A5017660016 @default.
• W2592012037 hasAuthorship W2592012037A5037974804 @default.
• W2592012037 hasAuthorship W2592012037A5050090015 @default.
• W2592012037 hasAuthorship W2592012037A5053329507 @default.
• W2592012037 hasAuthorship W2592012037A5057611294 @default.
• W2592012037 hasAuthorship W2592012037A5083824515 @default.
• W2592012037 hasConcept C104317684 @default.
• W2592012037 hasConcept C121608353 @default.
• W2592012037 hasConcept C125593758 @default.
• W2592012037 hasConcept C127561419 @default.
• W2592012037 hasConcept C142724271 @default.
• W2592012037 hasConcept C153911025 @default.
• W2592012037 hasConcept C154317977 @default.
• W2592012037 hasConcept C202751555 @default.
• W2592012037 hasConcept C2776256026 @default.
• W2592012037 hasConcept C2780192828 @default.
• W2592012037 hasConcept C502942594 @default.
• W2592012037 hasConcept C54355233 @default.
• W2592012037 hasConcept C55493867 @default.
• W2592012037 hasConcept C71924100 @default.
• W2592012037 hasConcept C81729549 @default.
• W2592012037 hasConcept C81885089 @default.
• W2592012037 hasConcept C86803240 @default.
• W2592012037 hasConcept C94581717 @default.
• W2592012037 hasConcept C96232424 @default.
• W2592012037 hasConceptScore W2592012037C104317684 @default.
• W2592012037 hasConceptScore W2592012037C121608353 @default.
• W2592012037 hasConceptScore W2592012037C125593758 @default.
• W2592012037 hasConceptScore W2592012037C127561419 @default.
• W2592012037 hasConceptScore W2592012037C142724271 @default.
• W2592012037 hasConceptScore W2592012037C153911025 @default.
• W2592012037 hasConceptScore W2592012037C154317977 @default.
• W2592012037 hasConceptScore W2592012037C202751555 @default.
• W2592012037 hasConceptScore W2592012037C2776256026 @default.
• W2592012037 hasConceptScore W2592012037C2780192828 @default.
• W2592012037 hasConceptScore W2592012037C502942594 @default.
• W2592012037 hasConceptScore W2592012037C54355233 @default.
• W2592012037 hasConceptScore W2592012037C55493867 @default.
• W2592012037 hasConceptScore W2592012037C71924100 @default.
• W2592012037 hasConceptScore W2592012037C81729549 @default.
• W2592012037 hasConceptScore W2592012037C81885089 @default.
• W2592012037 hasConceptScore W2592012037C86803240 @default.
• W2592012037 hasConceptScore W2592012037C94581717 @default.
• W2592012037 hasConceptScore W2592012037C96232424 @default.
• W2592012037 hasLocation W25920120371 @default.
• W2592012037 hasLocation W25920120372 @default.
• W2592012037 hasOpenAccess W2592012037 @default.
• W2592012037 hasPrimaryLocation W25920120371 @default.
• W2592012037 hasRelatedWork W1985538428 @default.
• W2592012037 hasRelatedWork W2005146652 @default.
• W2592012037 hasRelatedWork W2108027709 @default.

• next